Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 2 | 2023 | 67 | 1.550 |
Why?
|
| Coronary Artery Bypass | 14 | 2017 | 103 | 1.270 |
Why?
|
| Thoracoscopy | 2 | 2018 | 9 | 1.180 |
Why?
|
| Atrial Fibrillation | 4 | 2020 | 322 | 1.070 |
Why?
|
| Propofol | 2 | 2022 | 19 | 0.940 |
Why?
|
| Cardiac Tamponade | 1 | 2023 | 8 | 0.920 |
Why?
|
| Atrial Flutter | 1 | 2023 | 14 | 0.920 |
Why?
|
| Hemodynamics | 15 | 2023 | 155 | 0.880 |
Why?
|
| Methohexital | 1 | 2022 | 4 | 0.850 |
Why?
|
| Vasoconstriction | 1 | 2022 | 43 | 0.850 |
Why?
|
| Humans | 56 | 2023 | 32005 | 0.760 |
Why?
|
| Intubation, Intratracheal | 3 | 2017 | 71 | 0.740 |
Why?
|
| Goals | 1 | 2020 | 36 | 0.710 |
Why?
|
| Bronchoscopy | 2 | 2017 | 47 | 0.660 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 85 | 0.640 |
Why?
|
| Prospective Studies | 12 | 2023 | 2282 | 0.630 |
Why?
|
| Cardiology | 1 | 2019 | 99 | 0.620 |
Why?
|
| Bronchi | 1 | 2017 | 33 | 0.570 |
Why?
|
| Stents | 2 | 2008 | 177 | 0.560 |
Why?
|
| Postoperative Complications | 6 | 2017 | 780 | 0.540 |
Why?
|
| Cardiotonic Agents | 9 | 2006 | 48 | 0.510 |
Why?
|
| Collateral Circulation | 1 | 2015 | 9 | 0.510 |
Why?
|
| Coronary Thrombosis | 3 | 2009 | 14 | 0.500 |
Why?
|
| Coronary Circulation | 1 | 2015 | 43 | 0.490 |
Why?
|
| Heart Failure | 2 | 2020 | 639 | 0.480 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2011 | 73 | 0.470 |
Why?
|
| Blood Loss, Surgical | 2 | 2011 | 49 | 0.460 |
Why?
|
| Myocardial Ischemia | 5 | 2002 | 107 | 0.410 |
Why?
|
| Coronary Vessels | 2 | 2015 | 165 | 0.400 |
Why?
|
| Pulmonary Atelectasis | 1 | 2011 | 2 | 0.390 |
Why?
|
| Epinephrine | 7 | 1998 | 40 | 0.390 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 6 | 0.390 |
Why?
|
| Antifibrinolytic Agents | 1 | 2011 | 16 | 0.390 |
Why?
|
| Mediastinal Neoplasms | 1 | 2011 | 13 | 0.380 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 401 | 0.380 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2007 | 56 | 0.380 |
Why?
|
| Intraoperative Complications | 2 | 2011 | 56 | 0.380 |
Why?
|
| Amrinone | 5 | 1998 | 5 | 0.350 |
Why?
|
| Male | 35 | 2023 | 19165 | 0.350 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 510 | 0.320 |
Why?
|
| Anesthesia | 4 | 2011 | 64 | 0.320 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 1999 | 61 | 0.320 |
Why?
|
| Oxygen | 4 | 2020 | 142 | 0.310 |
Why?
|
| Middle Aged | 28 | 2017 | 11817 | 0.310 |
Why?
|
| Risk Factors | 5 | 2020 | 3876 | 0.310 |
Why?
|
| Perioperative Care | 1 | 2008 | 59 | 0.300 |
Why?
|
| Heart Rate | 11 | 2007 | 335 | 0.300 |
Why?
|
| Surgical Procedures, Operative | 1 | 2008 | 84 | 0.290 |
Why?
|
| Dobutamine | 5 | 1998 | 69 | 0.290 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 62 | 0.280 |
Why?
|
| Electric Countershock | 2 | 2022 | 11 | 0.280 |
Why?
|
| Aged, 80 and over | 6 | 2023 | 3990 | 0.270 |
Why?
|
| Female | 31 | 2017 | 19959 | 0.240 |
Why?
|
| Dopamine | 3 | 2006 | 232 | 0.230 |
Why?
|
| Positive-Pressure Respiration | 1 | 2023 | 9 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.220 |
Why?
|
| Pulmonary Circulation | 1 | 2022 | 4 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2016 | 290 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.210 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2002 | 4 | 0.210 |
Why?
|
| Fentanyl | 5 | 1991 | 32 | 0.210 |
Why?
|
| Postoperative Care | 2 | 2007 | 76 | 0.200 |
Why?
|
| Propanolamines | 2 | 1999 | 11 | 0.190 |
Why?
|
| Postoperative Period | 3 | 2017 | 97 | 0.190 |
Why?
|
| Lung | 1 | 2022 | 249 | 0.190 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 1997 | 22 | 0.190 |
Why?
|
| Aged | 17 | 2017 | 10301 | 0.180 |
Why?
|
| Nitroglycerin | 1 | 2000 | 11 | 0.180 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 62 | 0.180 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2007 | 9 | 0.180 |
Why?
|
| Consensus | 1 | 2019 | 85 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 940 | 0.170 |
Why?
|
| Anesthetics | 2 | 1989 | 18 | 0.170 |
Why?
|
| Aorta | 1 | 2019 | 126 | 0.160 |
Why?
|
| Coronary Restenosis | 2 | 2008 | 13 | 0.160 |
Why?
|
| Isoproterenol | 2 | 1997 | 16 | 0.160 |
Why?
|
| Double-Blind Method | 8 | 2000 | 525 | 0.160 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2018 | 12 | 0.150 |
Why?
|
| Ischemia | 1 | 2018 | 98 | 0.150 |
Why?
|
| Calcium | 4 | 1992 | 307 | 0.150 |
Why?
|
| Cardiac Output, Low | 2 | 1994 | 10 | 0.150 |
Why?
|
| Tachycardia | 1 | 1997 | 4 | 0.150 |
Why?
|
| Premedication | 1 | 1997 | 13 | 0.150 |
Why?
|
| Electroconvulsive Therapy | 1 | 1997 | 28 | 0.150 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 30 | 0.150 |
Why?
|
| Heart | 4 | 1995 | 177 | 0.150 |
Why?
|
| Pharyngitis | 1 | 2017 | 10 | 0.140 |
Why?
|
| Cardiac Output | 5 | 1995 | 36 | 0.140 |
Why?
|
| Preanesthetic Medication | 2 | 2002 | 3 | 0.140 |
Why?
|
| Mental Recall | 1 | 1996 | 51 | 0.140 |
Why?
|
| Random Allocation | 1 | 2017 | 226 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2020 | 1817 | 0.130 |
Why?
|
| Incidence | 1 | 2019 | 1199 | 0.130 |
Why?
|
| Adult | 10 | 2017 | 9345 | 0.130 |
Why?
|
| Anesthesiology | 1 | 1996 | 49 | 0.130 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 178 | 0.130 |
Why?
|
| Bronchial Diseases | 1 | 1995 | 4 | 0.130 |
Why?
|
| Hemoptysis | 1 | 1995 | 3 | 0.130 |
Why?
|
| Hodgkin Disease | 2 | 2011 | 9 | 0.130 |
Why?
|
| Physician-Patient Relations | 1 | 1996 | 185 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 1996 | 240 | 0.120 |
Why?
|
| Dopamine Agents | 1 | 1994 | 19 | 0.120 |
Why?
|
| Anesthesia, Inhalation | 2 | 2011 | 16 | 0.120 |
Why?
|
| Anesthesia, Intravenous | 3 | 1989 | 6 | 0.110 |
Why?
|
| Myocardial Infarction | 5 | 2000 | 475 | 0.100 |
Why?
|
| Critical Illness | 1 | 1993 | 87 | 0.100 |
Why?
|
| Magnesium Sulfate | 2 | 1991 | 14 | 0.100 |
Why?
|
| Hypertension | 2 | 1997 | 959 | 0.100 |
Why?
|
| Calcium Chloride | 1 | 1992 | 2 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2020 | 3306 | 0.100 |
Why?
|
| Dexmedetomidine | 1 | 2011 | 8 | 0.100 |
Why?
|
| Coronary Vasospasm | 1 | 1991 | 4 | 0.100 |
Why?
|
| Splanchnic Circulation | 1 | 2011 | 3 | 0.100 |
Why?
|
| Bradycardia | 1 | 2011 | 16 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 28 | 0.100 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 98 | 0.090 |
Why?
|
| Kidney | 1 | 1994 | 518 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 45 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2010 | 25 | 0.090 |
Why?
|
| Biopsy | 1 | 2011 | 259 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 1998 | 633 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2002 | 89 | 0.090 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 55 | 0.090 |
Why?
|
| Etomidate | 1 | 1989 | 5 | 0.090 |
Why?
|
| Drug Interactions | 4 | 1997 | 78 | 0.090 |
Why?
|
| Pentobarbital | 2 | 1988 | 4 | 0.080 |
Why?
|
| Heart Atria | 1 | 2009 | 65 | 0.080 |
Why?
|
| Ticlopidine | 1 | 2008 | 17 | 0.080 |
Why?
|
| Drug-Eluting Stents | 1 | 2008 | 13 | 0.080 |
Why?
|
| Echocardiography | 1 | 2009 | 159 | 0.080 |
Why?
|
| Anesthesia, Conduction | 1 | 2008 | 25 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 2 | 2006 | 42 | 0.080 |
Why?
|
| Aspirin | 1 | 2008 | 63 | 0.080 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1988 | 5 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 83 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2016 | 898 | 0.080 |
Why?
|
| Medical Errors | 1 | 2007 | 36 | 0.070 |
Why?
|
| Cyclic AMP | 2 | 1998 | 46 | 0.070 |
Why?
|
| Intraoperative Care | 1 | 2006 | 48 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2006 | 199 | 0.060 |
Why?
|
| Blood Pressure | 6 | 2006 | 845 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 170 | 0.060 |
Why?
|
| Myocardial Contraction | 5 | 1998 | 63 | 0.060 |
Why?
|
| Young Adult | 1 | 2011 | 2636 | 0.060 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 6 | 0.050 |
Why?
|
| Coronary Disease | 2 | 1997 | 211 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 2006 | 28 | 0.050 |
Why?
|
| Sex Factors | 2 | 1996 | 663 | 0.050 |
Why?
|
| Age Factors | 3 | 1996 | 1188 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1514 | 0.050 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 1999 | 3 | 0.040 |
Why?
|
| Time Factors | 5 | 2011 | 2149 | 0.040 |
Why?
|
| Sufentanil | 2 | 1989 | 5 | 0.040 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 29 | 0.040 |
Why?
|
| Length of Stay | 2 | 1999 | 314 | 0.040 |
Why?
|
| Antioxidants | 1 | 1999 | 115 | 0.040 |
Why?
|
| Animals | 7 | 1997 | 7541 | 0.040 |
Why?
|
| Heparin | 2 | 1990 | 73 | 0.040 |
Why?
|
| Adrenergic Agonists | 1 | 1998 | 5 | 0.040 |
Why?
|
| Heart Valves | 1 | 1998 | 16 | 0.040 |
Why?
|
| Lymphocytes | 1 | 1998 | 57 | 0.040 |
Why?
|
| Heart Conduction System | 2 | 1988 | 72 | 0.040 |
Why?
|
| Myocardium | 2 | 1997 | 186 | 0.040 |
Why?
|
| Renal Circulation | 1 | 1997 | 13 | 0.040 |
Why?
|
| Sympathetic Nervous System | 1 | 1997 | 31 | 0.040 |
Why?
|
| Electrocardiography | 3 | 1999 | 605 | 0.040 |
Why?
|
| Nausea | 1 | 1997 | 53 | 0.040 |
Why?
|
| Chromonar | 1 | 1997 | 1 | 0.040 |
Why?
|
| Coumarins | 1 | 1997 | 1 | 0.040 |
Why?
|
| Myocardial Reperfusion | 1 | 1997 | 10 | 0.040 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1997 | 17 | 0.040 |
Why?
|
| Hospital-Patient Relations | 1 | 1996 | 3 | 0.040 |
Why?
|
| Intraoperative Period | 2 | 1999 | 42 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1999 | 78 | 0.030 |
Why?
|
| Telephone | 1 | 1996 | 59 | 0.030 |
Why?
|
| Stimulation, Chemical | 2 | 1995 | 13 | 0.030 |
Why?
|
| Anticoagulants | 1 | 1997 | 122 | 0.030 |
Why?
|
| Pyridones | 1 | 1995 | 10 | 0.030 |
Why?
|
| General Surgery | 1 | 1996 | 88 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 1995 | 7 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1995 | 10 | 0.030 |
Why?
|
| Attitude to Health | 1 | 1996 | 165 | 0.030 |
Why?
|
| Diuresis | 1 | 1994 | 6 | 0.030 |
Why?
|
| Natriuresis | 1 | 1994 | 4 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1994 | 108 | 0.030 |
Why?
|
| Logistic Models | 1 | 1996 | 781 | 0.030 |
Why?
|
| Splenectomy | 1 | 1974 | 21 | 0.030 |
Why?
|
| Health Status | 1 | 1996 | 399 | 0.030 |
Why?
|
| Dogs | 3 | 1988 | 120 | 0.030 |
Why?
|
| Ventricular Function, Left | 3 | 2006 | 245 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2011 | 3509 | 0.030 |
Why?
|
| Ephedrine | 1 | 1992 | 3 | 0.030 |
Why?
|
| Shock | 1 | 1993 | 30 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1993 | 288 | 0.030 |
Why?
|
| Drug Combinations | 2 | 1989 | 98 | 0.030 |
Why?
|
| Pulmonary Artery | 2 | 1992 | 24 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1992 | 100 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 1991 | 13 | 0.020 |
Why?
|
| Nitroprusside | 1 | 1991 | 5 | 0.020 |
Why?
|
| Hypothermia, Induced | 1 | 1991 | 17 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 1991 | 30 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 1991 | 45 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1993 | 301 | 0.020 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1990 | 1 | 0.020 |
Why?
|
| Protamines | 1 | 1990 | 4 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1991 | 93 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 51 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 106 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 158 | 0.020 |
Why?
|
| Lorazepam | 1 | 1989 | 3 | 0.020 |
Why?
|
| Scopolamine | 1 | 1989 | 5 | 0.020 |
Why?
|
| Succinylcholine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Equipment Safety | 1 | 1989 | 20 | 0.020 |
Why?
|
| Halothane | 1 | 1988 | 1 | 0.020 |
Why?
|
| Verapamil | 1 | 1988 | 8 | 0.020 |
Why?
|
| Atrioventricular Node | 1 | 1988 | 5 | 0.020 |
Why?
|
| Propranolol | 1 | 1988 | 16 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 232 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1991 | 876 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1988 | 70 | 0.020 |
Why?
|
| Edrophonium | 1 | 1987 | 1 | 0.020 |
Why?
|
| Isoflurane | 1 | 1987 | 1 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 379 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1987 | 7 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1987 | 15 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1987 | 24 | 0.020 |
Why?
|
| Catheterization | 1 | 1987 | 58 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1987 | 46 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1987 | 72 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2007 | 24 | 0.020 |
Why?
|
| Prognosis | 1 | 1991 | 1497 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1987 | 100 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2007 | 39 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2006 | 42 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 2006 | 41 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2006 | 135 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1989 | 44 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 1998 | 684 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2265 | 0.010 |
Why?
|
| Stroke Volume | 2 | 1992 | 348 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1999 | 114 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1999 | 371 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 197 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1998 | 833 | 0.010 |
Why?
|
| Milrinone | 1 | 1995 | 2 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1995 | 14 | 0.010 |
Why?
|
| Thyroxine | 1 | 1995 | 16 | 0.010 |
Why?
|
| Radioisotope Teletherapy | 1 | 1974 | 1 | 0.010 |
Why?
|
| Splenic Neoplasms | 1 | 1974 | 1 | 0.010 |
Why?
|
| Cobalt Radioisotopes | 1 | 1974 | 3 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1974 | 29 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1974 | 49 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1974 | 101 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1974 | 39 | 0.010 |
Why?
|
| Leukocytes | 1 | 1974 | 57 | 0.010 |
Why?
|
| Spleen | 1 | 1974 | 87 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1974 | 107 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 743 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1992 | 13 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 1992 | 17 | 0.010 |
Why?
|
| Placebos | 1 | 1992 | 63 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1992 | 31 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1992 | 99 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 25 | 0.010 |
Why?
|
| Hypotension, Controlled | 1 | 1991 | 1 | 0.010 |
Why?
|
| Magnesium | 1 | 1991 | 30 | 0.010 |
Why?
|
| Calcitriol | 1 | 1991 | 25 | 0.010 |
Why?
|
| Rats | 1 | 1995 | 1595 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1988 | 2 | 0.010 |
Why?
|
| Vecuronium Bromide | 1 | 1987 | 1 | 0.000 |
Why?
|
| Pancuronium | 1 | 1987 | 2 | 0.000 |
Why?
|
| Nitrous Oxide | 1 | 1987 | 4 | 0.000 |
Why?
|
| Platelet Count | 1 | 1987 | 23 | 0.000 |
Why?
|
| Atropine | 1 | 1987 | 22 | 0.000 |
Why?
|
| Probability | 1 | 1987 | 158 | 0.000 |
Why?
|
| Child | 1 | 1974 | 2438 | 0.000 |
Why?
|
| Equipment Design | 1 | 1987 | 171 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1987 | 293 | 0.000 |
Why?
|
| Blood Pressure Determination | 1 | 1987 | 100 | 0.000 |
Why?
|
| Adolescent | 1 | 1974 | 3539 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1987 | 762 | 0.000 |
Why?
|